EPA-Approved SARS-CoV-2 Disinfectants
6 rows where "Date_on_List_N" is on date 2023-02-27 sorted by Surface_type
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient, Contact_time, Formulation_type, Why_on_List_N,
ID
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type ▼
|
Contact_time
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
2540 |
10324-241 |
Increased Risk |
Quaternary ammonium |
Maquat 2.75-FD |
Mason Chemical Company |
Hospital; Institutional; Residential |
Hard Nonporous (HN) |
2.0 minutes |
Dilutable |
SARS-CoV-2 |
2023-02-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2541 |
10324-242 |
Increased Risk |
Quaternary ammonium |
Maquat 5.5-D |
Mason Chemical Company |
Hospital; Institutional; Residential |
Hard Nonporous (HN) |
2.0 minutes |
Dilutable |
SARS-CoV-2 |
2023-02-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2542 |
10324-238 |
Increased Risk |
Quaternary ammonium |
Maquat 11-D |
Mason Chemical Company |
Hospital; Institutional; Residential |
Hard Nonporous (HN) |
2.0 minutes |
Dilutable |
SARS-CoV-2 |
2023-02-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2543 |
10324-240 |
Increased Risk |
Quaternary ammonium |
Maquat 2.75-D |
Mason Chemical Company |
Hospital; Institutional; Residential |
Hard Nonporous (HN) |
2.0 minutes |
Dilutable |
SARS-CoV-2 |
2023-02-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2544 |
34810-35 |
Safer |
Citric acid |
Cleancide |
Wexford Labs, Inc. |
Hospital; Institutional; Residential |
Hard Nonporous (HN) |
5.0 minutes |
Ready-to-use |
Feline calicivirus |
2023-02-27 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2545 |
99764-1 |
Increased Risk |
Hypochlorous acid |
Everyday Disinfectant |
Dear Planet Labs Inc. |
Hospital; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Ready-to-use |
SARS-CoV-2 |
2023-02-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |